A 48-week real-world effectiveness of nemolizumab for pediatric patients with atopic dermatitis

Journal of the American Academy of Dermatology · Published 2026-08-01 · DOI 10.1016/j.jaad.2026.07.118

Authors (5)

Teppei Hagino, Yohei Takahashi, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Hagino, T., Takahashi, Y., Saeki, H., et al. (2026). A 48-week real-world effectiveness of nemolizumab for pediatric patients with atopic dermatitis. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.07.118

Related articles